Long-Term Outcomes of Endoscopic Ultrasound–Guided Ablation Vs Surgery for Pancreatic Cystic Tumors
Clinical Gastroenterology and Hepatology · 2024
DOI: 10.1016/j.cgh.2024.03.021 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Clinical Gastroenterology and Hepatology, 2024. Verfasst von Sung Hyun Cho und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Pancreatic Cyst. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND & AIMS: Endoscopic ultrasound-guided pancreatic cyst ablation (EUS-PCA) is performed as an alternative to surgical resection in selected patients with pancreatic cystic tumors (PCTs). We aimed to directly compare the long-term outcomes between EUS-PCA and surgery for PCTs. METHODS: We reviewed a PCT database to identify patients with unilocular or oligolocular PCTs who underwent EUS-PCA or surgery between January 2004 and July 2019. We performed 1:1 propensity score matching based on potential confounding factors. The primary outcome was long-term morbidities. Secondary outcomes included early (≤14 days) and late (>14 days) major adverse events (MAEs), development of diabetes mellitus, readmission, length of hospital stay, and therapeutic efficacy. RESULTS: A total of 620 patients (EUS-PCA, n = 310; surgery, n = 310) were selected after propensity score matching. The EUS-PCA group showed a lower 10-year rate of cumulative long-term morbidities (1.6% vs 33.5%; P = .001) as well as lower rates of early MAE (1.0% vs 8.7%; P = .001), late MAE (0.3% vs 5.5%; P = .001), and readmission (1.0% vs 15.2%; P = .001). The EUS-PCA group had a shorter hospital stay (3.5 vs 10.3 d; P = .001) and a lower incidence of diabetes mellitus (2.2% vs 22.8%; P = .001), whereas the surgery group had a higher complete resolution rate (76.5% vs 100%; P = .001) and a lower relapse rate (4.6% vs 0.3%; P = .001). CONCLUSIONS: For select patients with PCTs, EUS-PCA showed superior results to surgery in terms of long-term safety profile and preservation of pancreatic function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
- Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. Electronic address: dwseoamc@amc.seoul.kr.
Zitieren
APA
Cho, S. H., Seo, D. W., Oh, D., Song, T. J., & Lee, S. K. (2024). Long-Term Outcomes of Endoscopic Ultrasound–Guided Ablation Vs Surgery for Pancreatic Cystic Tumors. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2024.03.021
Vancouver
Cho SH, Seo DW, Oh D, Song TJ, Lee SK. Long-Term Outcomes of Endoscopic Ultrasound–Guided Ablation Vs Surgery for Pancreatic Cystic Tumors. Clinical Gastroenterology and Hepatology. 2024. doi:10.1016/j.cgh.2024.03.021
BibTeX
@article{Cho2024,
author = {Cho, Sung Hyun and Seo, Dong-Wan and Oh, Dongwook and Song, Tae Jun and Lee, Sung Koo},
title = {Long-Term Outcomes of Endoscopic Ultrasound–Guided Ablation Vs Surgery for Pancreatic Cystic Tumors},
journal = {Clinical Gastroenterology and Hepatology},
year = {2024},
doi = {10.1016/j.cgh.2024.03.021}
}
EUVIMED